Comments
Loading...
Halozyme Therapeutics Informe de interés a corto plazo
HALONASDAQ
Informe de interés en corto
El interés corto en Halozyme Therapeutics Inc (NASDAQ:HALO) ha aumentado durante el último período de informe, aumentando en aumento desde 9.60M hasta 9.93M. Esto representa el 11.86% de las acciones disponibles públicamente de la empresa.
El interés en corto en Halozyme Therapeutics Corp (XNAS:HALO) disminuyó durante el último período de informe, cayendo de 280,30 millones a 275,20 millones. Esto hizo que el 1,17 % de las acciones disponibles públicamente de la empresa se pusieran en corto.
Basado en el volumen promedio reciente de 1.25M acciones negociadas por día, tomaría 7.95 día(s) para que los poseedores de este interés corto cierren sus posiciones sin impulsar bruscamente el precio de las acciones.
Interés en corto
9.93M
Interés en corto %
11.9%
Días para cubrir
7.95
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
HALO | Halozyme Therapeutics, Inc. Co | 07/31/2025 | 08/11/2025 | 11.86% | 83,777,977 | 9,932,500 | 1,249,951 | 7.95 | |
HALO | Halozyme Therapeutics, Inc. Co | 07/15/2025 | 07/24/2025 | 10.67% | 90,032,977 | 9,602,474 | 1,558,889 | 6.16 | |
HALO | Halozyme Therapeutics, Inc. Co | 06/30/2025 | 07/10/2025 | 11.30% | 90,032,977 | 10,176,028 | 4,223,614 | 2.41 | |
HALO | Halozyme Therapeutics, Inc. Co | 06/13/2025 | 06/25/2025 | 12.29% | 90,032,977 | 11,065,499 | 1,648,108 | 6.71 | |
HALO | Halozyme Therapeutics, Inc. Co | 05/30/2025 | 06/10/2025 | 11.72% | 90,032,977 | 10,551,963 | 2,027,055 | 5.21 | |
HALO | Halozyme Therapeutics, Inc. Co | 05/15/2025 | 05/27/2025 | 11.87% | 90,032,977 | 10,690,600 | 4,533,203 | 2.36 | |
HALO | Halozyme Therapeutics, Inc. Co | 04/30/2025 | 05/09/2025 | 10.51% | 90,032,977 | 9,462,038 | 1,291,786 | 7.32 | |
HALO | Halozyme Therapeutics, Inc. Co | 04/15/2025 | 04/25/2025 | 10.65% | 90,345,287 | 9,619,716 | 1,800,888 | 5.34 | |
HALO | Halozyme Therapeutics, Inc. Co | 03/31/2025 | 04/09/2025 | 10.21% | 90,345,287 | 9,221,727 | 1,682,855 | 5.48 | |
HALO | Halozyme Therapeutics, Inc. Co | 03/14/2025 | 03/25/2025 | 11.15% | 90,345,287 | 10,069,735 | 1,455,005 | 6.92 | |
HALO | Halozyme Therapeutics, Inc. Co | 02/28/2025 | 03/11/2025 | 10.83% | 89,982,739 | 9,748,013 | 1,365,287 | 7.14 | |
HALO | Halozyme Therapeutics, Inc. Co | 02/14/2025 | 02/26/2025 | 10.25% | 89,982,739 | 9,221,430 | 977,109 | 9.44 | |
HALO | Halozyme Therapeutics, Inc. Co | 01/31/2025 | 02/11/2025 | 9.63% | 94,056,739 | 9,055,762 | 1,072,280 | 8.45 | |
HALO | Halozyme Therapeutics, Inc. Co | 01/15/2025 | 01/27/2025 | 10.00% | 94,056,739 | 9,405,294 | 1,757,468 | 5.35 | |
HALO | Halozyme Therapeutics, Inc. Co | 12/31/2024 | 01/10/2025 | 10.16% | 93,508,019 | 9,504,876 | 1,532,701 | 6.2 | |
HALO | Halozyme Therapeutics, Inc. Co | 12/13/2024 | 12/24/2024 | 9.40% | 93,508,019 | 8,789,545 | 1,016,508 | 8.65 | |
HALO | Halozyme Therapeutics, Inc. Co | 11/29/2024 | 12/10/2024 | 9.16% | 93,508,019 | 8,566,431 | 2,558,102 | 3.35 | |
HALO | Halozyme Therapeutics, Inc. Co | 11/15/2024 | 11/26/2024 | 11.18% | 93,508,019 | 10,450,111 | 2,203,379 | 4.74 | |
HALO | Halozyme Therapeutics, Inc. Co | 10/31/2024 | 11/11/2024 | 10.96% | 93,508,019 | 10,249,324 | 1,028,448 | 9.97 | |
HALO | Halozyme Therapeutics, Inc. Co | 10/15/2024 | 10/24/2024 | 11.14% | 93,508,019 | 10,416,746 | 1,641,838 | 6.34 | |
HALO | Halozyme Therapeutics, Inc. Co | 09/30/2024 | 10/09/2024 | 10.54% | 93,508,019 | 9,854,920 | 1,484,928 | 6.64 | |
HALO | Halozyme Therapeutics, Inc. Co | 09/13/2024 | 09/24/2024 | 10.30% | 93,508,019 | 9,635,995 | 1,102,235 | 8.74 | |
HALO | Halozyme Therapeutics, Inc. Co | 08/30/2024 | 09/11/2024 | 10.74% | 93,508,019 | 10,040,022 | 1,296,147 | 7.75 | |
HALO | Halozyme Therapeutics, Inc. Co | 08/15/2024 | 08/26/2024 | 10.35% | 93,508,019 | 9,673,467 | 1,341,528 | 7.21 | |
HALO | Halozyme Therapeutics, Inc. Co | 07/31/2024 | 08/09/2024 | 9.57% | 93,508,019 | 8,945,252 | 1,122,076 | 7.97 | |
HALO | Halozyme Therapeutics, Inc. Co | 07/15/2024 | 07/24/2024 | 9.25% | 94,103,739 | 8,708,189 | 1,302,955 | 6.68 | |
HALO | Halozyme Therapeutics, Inc. Co | 06/28/2024 | 07/10/2024 | 9.59% | 94,103,739 | 9,024,638 | 1,487,993 | 6.06 | |
HALO | Halozyme Therapeutics, Inc. Co | 06/14/2024 | 06/26/2024 | 9.89% | 94,103,739 | 9,308,538 | 1,684,971 | 5.52 | |
HALO | Halozyme Therapeutics, Inc. Co | 05/31/2024 | 06/11/2024 | 9.10% | 94,103,739 | 8,562,180 | 966,154 | 8.86 | |
HALO | Halozyme Therapeutics, Inc. Co | 05/15/2024 | 05/24/2024 | 9.10% | 94,103,739 | 8,558,777 | 1,157,005 | 7.4 | |
HALO | Halozyme Therapeutics, Inc. Co | 04/30/2024 | 05/09/2024 | 8.93% | 94,103,739 | 8,406,488 | 719,397 | 11.69 | |
HALO | Halozyme Therapeutics, Inc. Co | 04/15/2024 | 04/24/2024 | 8.78% | 93,883,979 | 8,238,441 | 980,032 | 8.41 | |
HALO | Halozyme Therapeutics, Inc. Co | 03/28/2024 | 04/09/2024 | 8.40% | 93,883,979 | 7,885,978 | 772,456 | 10.21 | |
HALO | Halozyme Therapeutics, Inc. Co | 03/15/2024 | 03/26/2024 | 8.74% | 93,883,979 | 8,201,639 | 1,083,698 | 7.57 | |
HALO | Halozyme Therapeutics, Inc. Co | 02/29/2024 | 03/11/2024 | 8.61% | 93,883,979 | 8,082,695 | 1,409,031 | 5.74 | |
HALO | Halozyme Therapeutics, Inc. Co | 02/15/2024 | 02/27/2024 | 7.19% | 106,408,913 | 7,647,117 | 1,035,888 | 7.38 | |
HALO | Halozyme Therapeutics, Inc. Co | 01/31/2024 | 02/09/2024 | 6.84% | 111,682,223 | 7,637,269 | 1,820,412 | 4.2 | |
HALO | Halozyme Therapeutics, Inc. Co | 01/12/2024 | 01/24/2024 | 6.42% | 111,682,223 | 7,165,717 | 1,813,213 | 3.95 | |
HALO | Halozyme Therapeutics, Inc. Co | 12/29/2023 | 01/10/2024 | 6.58% | 111,682,223 | 7,349,534 | 1,140,204 | 6.45 | |
HALO | Halozyme Therapeutics, Inc. Co | 12/15/2023 | 12/27/2023 | 6.71% | 111,682,223 | 7,499,289 | 983,474 | 7.63 | |
HALO | Halozyme Therapeutics, Inc. Co | 11/30/2023 | 12/11/2023 | 6.38% | 111,682,223 | 7,126,171 | 832,547 | 8.56 | |
HALO | Halozyme Therapeutics, Inc. Co | 11/15/2023 | 11/27/2023 | 6.24% | 111,682,223 | 6,974,433 | 1,290,654 | 5.4 | |
HALO | Halozyme Therapeutics, Inc. Co | 10/31/2023 | 11/09/2023 | 5.90% | 111,682,223 | 6,583,869 | 731,381 | 9 | |
HALO | Halozyme Therapeutics, Inc. Co | 10/13/2023 | 10/24/2023 | 5.93% | 111,504,993 | 6,610,481 | 666,460 | 9.92 | |
HALO | Halozyme Therapeutics, Inc. Co | 09/29/2023 | 10/10/2023 | 5.80% | 111,504,993 | 6,463,828 | 725,308 | 8.91 | |
HALO | Halozyme Therapeutics, Inc. Co | 09/15/2023 | 09/26/2023 | 6.14% | 111,504,993 | 6,844,955 | 1,129,494 | 6.06 | |
HALO | Halozyme Therapeutics, Inc. Co | 08/31/2023 | 09/12/2023 | 6.14% | 111,504,993 | 6,840,917 | 690,487 | 9.91 | |
HALO | Halozyme Therapeutics, Inc. Co | 08/15/2023 | 08/24/2023 | 6.55% | 111,504,993 | 7,301,567 | 973,086 | 7.5 |
En busca de los valores más cortos?